ClusterOS Diagnostic Profile
ESES Life Sciences
ESES Life Sciences runs on 87 evidence items (ESES Life Sciences UKRI grants: 590 grants, £626m total, 55 distinct lead org). The diagnostic resolves a Extraction-Narrative configuration at HIGH confidence.
Value extraction events generate narrative about ecosystem success; narrative legitimises continued extraction by framing it as ecosystem contribution; uncertainty about whether extraction is harmful absorbed by the success narrative.
Intermediaries produce narrative about their facilitation role; narrative legitimises intermediary existence and funding; uncertainty about direct coupling absorbed by narrative rather than demonstration.
"If UKRI grant reporting (P006: 590 grants, £626m) and City Region Deal reporting (P005) were required to distinguish between value created locally (revenue/employment in ESES region) and value extracted externally (spin-off HQ relocation, founder emigration, IP licensing to non-local firms), it might reduce the system's ability to absorb uncertainty about extraction by making the distinction between ecosystem contribution and ecosystem retention...
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.